Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial - Communications Medicine

Armstrong et al. conducted an open-label pilot trial of psilocybin-assisted therapy in U.S. military veterans with severe treatment-resistant PTSD. The therapy was safe and well-tolerated and produced large reductions in PTSD symptoms, with most participants achieving clinical response and remission.